Healthcare Australian Community

Pro Medicus (ASX: PME) is an Australian company that develops medical imaging software under its Visage product range. Leading medical institutions including NYU Langone, UCSF, and Mass General Brigham have publicly or semi-publicly praised the platform—often via PME-issued press releases or interviews.Read more

Monash IVF ( ASX: MVF ) Monash IVF Group Limited is a leading provider of assisted reproductive services in Australia and Malaysia. With over 50 years of experience, the company has been instrumental in pioneering fertility treatments, including achieving Australia's first IVF birth and the world's first pregnancy from a frozen embryo.Read more

Catalysts About Mach7 Technologies Mach7 Technologies delivers mission-critical enterprise imaging software that connects, manages and activates medical imaging data across health systems worldwide. What are the underlying business or industry changes driving this perspective?Read more

Key Takeaways Strategic acquisitions, partnerships, and regulatory approvals are poised to enhance market presence, revenue, and net margins through expanded distribution and high-margin services. Geographic expansion and new technology development aim to increase market penetration, scan volumes, and capture significant market share, improving overall financial performance.Read more

Catalysts About Imricor Medical Systems Imricor Medical Systems develops MRI compatible cardiac ablation systems that enable interventional electrophysiology procedures to be performed inside the MRI suite. What are the underlying business or industry changes driving this perspective?Read more

Catalysts About Integral Diagnostics Integral Diagnostics is a specialist provider of diagnostic imaging services across Australia and New Zealand, with a growing focus on higher value modalities and teleradiology. What are the underlying business or industry changes driving this perspective?Read more

Catalysts About Healius Healius operates a large-scale pathology and diagnostics network focused on laboratory testing and associated services across Australia. What are the underlying business or industry changes driving this perspective?Read more

Key Takeaways Shifting care models and regulatory changes threaten stable growth and could erode core hospital revenue and patient volumes across key markets. Rising costs, high debt, and political risks are compressing margins while undermining reliable profit growth despite ongoing investments and international presence.Read more

Key Takeaways Heavy reliance on the US and a narrow glaucoma-focused portfolio exposes the company to policy, regulatory, and obsolescence risks. Rising competition, payer pricing pressures, and limited geographic diversification threaten profitability, margin expansion, and sustained earnings growth.Read more